RecruitingPhase 2NCT07698886

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Sponsor

KTH Biopharma

Enrollment

70 participants

Start Date

Jul 16, 2026

Study Type

INTERVENTIONAL

Conditions

HPV (Human Papillomavirus)-Associated Genital warts

Summary

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Geniwa gel and Placebo gel for people with genital warts and hpv (human papillomavirus)-associated. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.